PetMed Express, Inc. (PETS)
Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Mathew N. Hulett | CEO, President & Director | 534.12k | -- | 1971 |
| Ms. Christine Chambers | CFO, Principal Financial Officer, Principal Accounting Officer, Treasurer & Secretary | 305.4k | -- | 1978 |
| Mr. Mark Moseley | Chief Technology & Information Officer | -- | -- | -- |
| Mr. Daniel Job Pingree | Chief Marketing Officer | -- | -- | -- |
| Ms. Jacqueline Smith | Vice President of People | -- | -- | -- |
| Wendy Zalai | Corporate Controller & Corporate Secretary | -- | -- | -- |
PetMed Express, Inc.
- Sector:
- Healthcare
- Industry: Pharmaceutical Retailers
- Full Time Employees:
- 302
Description
PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes. The company also sells food, beds, crates, stairs, and other pet supplies. It sells its products through its Internet website; mobile app; customer support center; and direct mail/print, which includes brochures and postcards, as well as television advertising under the 1-800-PetMeds, PetCare Rx, and PetMeds brands. The company was incorporated in 1996 and is headquartered in Delray Beach, Florida.
Corporate Governance
Recent Events
- Apr 15, 202410-Q/A: Periodic Financial ReportsSee Full Filing
- Feb 15, 20248-K: Corporate Changes & Voting MattersSee Full Filing
- Feb 09, 2024NT 10-Q: Periodic Financial ReportsSee Full Filing
- Feb 08, 20248-K: Corporate Changes & Voting MattersSee Full Filing
- Jan 25, 2024SC 13G/A: Tender Offer/Acquisition ReportsSee Full Filing